J B Chemicals And Pharmaceutical share price
You have to be logged in to add this to Watchlist.- ₹1,720.00(-1.44%)June 13, 2025 15:29:00 PM IST
- NSE
- BSE
- Vol : 152.34K (NSE + BSE)Last 20 day avg : 172.97 K
J B Chemicals And Pharmaceutical is trading -1.44% lower at Rs 1,720.00 as compared to its last closing price. J B Chemicals And Pharmaceutical has been trading in the price range of 1,740.65 & 1,689.05. J B Chemicals And Pharmaceutical has given -5.95% in this year & 1.89% in the last 5 days. J B Chemicals And Pharmaceutical has TTM P/E ratio 38.24 as compared to the sector P/E of 25.02.There are 12 analysts who have initiated coverage on J B Chemicals And Pharmaceutical. There are 7 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 145.69 Crores in its last quarter.Listed peers of J B Chemicals And Pharmaceutical include Wockhardt (-0.35%), Gland Pharma (1.48%), J B Chemicals And Pharmaceutical (-1.44%).The Mutual Fund holding in J B Chemicals And Pharmaceutical was at 16.26% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in J B Chemicals And Pharmaceutical was at 18.29% in 31 Mar 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Jun 15, 2025, 04:53 AM UTC
- Dividend YieldLower than industry0.89Annual dividends as a percentage of the stock price.
- P/BLower than historical values7.86The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values41.72Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.23Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 10.18% from Rs 949.48 crore to Rs 861.73 crore, year-on-year
- The company has grown its March quarter profit by 15.48% from Rs 126.16 crore to Rs 145.69 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 1,744.73
- R2
- 1,809.22
- R3
- 1,849.78
- S1
- 1,639.68
- S2
- 1,599.12
- S3
- 1,534.63
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Wockhardt | Bullish | 1,777.45 | -0.35 | 28,879.83 | - | 6.61 | - | 30.00 |
| Gland Pharma | Bullish | 1,691.35 | 1.48 | 27,866.08 | 39.85 | 3.04 | 1.07 | 1.17 |
| J B Chemicals And Pharmaceutical | Moderately Bullish | 1,720.00 | -1.44 | 27,125.89 | 41.73 | 7.86 | 0.71 | 0.19 |
| Piramal Pharma | Bearish | 200.70 | 0.38 | 26,678.01 | 294.44 | 3.26 | 0.05 | 40.78 |
| Syngene International | Neutral | 652.45 | -1.58 | 26,289.78 | 55.62 | 5.55 | 0.19 | 8.65 |
- Promoter(s) holding is moderate at 47.84%
Promoter(s) have decreased the stake in the company in last 12 months- FIIs are invested in this company
- FIIs holding has increased by 3.67 percentage points from previous quarter
- Mutual Funds holding has increased by 1.69 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-04 | Quarterly Results & Interim Dividend |
| 2024-11-06 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| 2024-05-17 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE572A01036
- BSE Code506943
- NSE CodeJBCHEPHARM
J B Chemicals And Pharmaceutical is trading at 1720.00 as on Fri Jun 13 2025 09:59:00. This is -1.44% lower as compared to its previous closing price of 1745.10.
The market capitalization of J B Chemicals And Pharmaceutical is 27125.89 Cr as on Fri Jun 13 2025 09:59:00.
The average broker rating on J B Chemicals And Pharmaceutical is Strong Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for J B Chemicals And Pharmaceutical is 2029.00 whereas the 52 wk low is 1303.00
J B Chemicals And Pharmaceutical can be analyzed on the following key metrics -
- TTM P/E: 38.24
- Sector P/E: 25.02
- Dividend Yield: 0.89%
- D/E ratio: 0.01
J B Chemicals And Pharmaceutical reported a net profit of 659.58 Cr in 2025.
The Mutual Fund Shareholding was 16.26% at the end of 31 Mar 2025.